90 filings
Page 2 of 5
SC 13D/A
Cochlear Ltd
29 Mar 23
Nyxoah / Cochlear ownership change
7:31am
6-K
NYXH
Nyxoah SA
27 Mar 23
Nyxoah Raises $3 Million from an At-the-Market Equity Offering
5:00pm
6-K
NYXH
Nyxoah SA
23 Mar 23
Nyxoah Announces a $15 Million Private Placement Financing
4:28pm
20-F
2022 FY
NYXH
Nyxoah SA
Annual report (foreign)
22 Mar 23
4:40pm
6-K
NYXH
Nyxoah SA
22 Mar 23
Nyxoah Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
4:14pm
6-K
NYXH
Nyxoah SA
15 Mar 23
Current report (foreign)
4:37pm
6-K
NYXH
Nyxoah SA
6 Mar 23
Nyxoah Announces Achievement of Key Clinical and Regulatory Milestones
4:57pm
S-8
NYXH
Nyxoah SA
25 Jan 23
Registration of securities for employees
4:33pm
6-K
NYXH
Nyxoah SA
9 Jan 23
Nyxoah Appoints Mr. Daniel Wildman to its Board of Directors
4:33pm
EFFECT
NYXH
Nyxoah SA
9 Jan 23
Notice of effectiveness
12:15am
CORRESP
NYXH
Nyxoah SA
4 Jan 23
Correspondence with SEC
12:00am
6-K
NYXH
Nyxoah SA
3 Jan 23
Information on the total number of voting rights and shares
4:10pm
UPLOAD
NYXH
Nyxoah SA
29 Dec 22
Letter from SEC
12:00am
6-K
NYXH
Nyxoah SA
22 Dec 22
Nyxoah Files Shelf Registration Statement and Announces At-the-Market Equity Offering Program
4:18pm
F-3
NYXH
Nyxoah SA
22 Dec 22
Shelf registration (foreign)
4:06pm
6-K
NYXH
Nyxoah SA
8 Nov 22
Nyxoah Reports Third Quarter 2022 Financial and Operating Results
4:13pm
6-K
NYXH
Nyxoah SA
24 Oct 22
Nyxoah announces Change to Board of Directors
4:48pm
6-K
NYXH
Nyxoah SA
19 Oct 22
Current report (foreign)
4:10pm
6-K
NYXH
Nyxoah SA
3 Oct 22
Information on the total number of voting rights and shares
4:11pm
6-K
NYXH
Nyxoah SA
8 Aug 22
Nyxoah Reports Second Quarter and First Half 2022 Financial and Operating Results
4:36pm